Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2002 1
2003 1
2004 1
2005 1
2006 2
2007 1
2008 3
2009 5
2010 4
2011 7
2012 2
2013 10
2014 3
2015 13
2016 12
2017 12
2018 12
2019 2
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 30373742

84 results
Results by year
Filters applied: . Clear all
Page 1
American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT; American Gastroenterological Association Institute. Reddy KR, et al. Gastroenterology. 2015 Jan;148(1):215-9; quiz e16-7. doi: 10.1053/j.gastro.2014.10.039. Epub 2014 Oct 31. Gastroenterology. 2015. PMID: 25447850 Review. No abstract available.
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy.
Marrone A, Capoluongo N, D'Amore C, Pisaturo M, Esposito M, Guastafierro S, Siniscalchi I, Macera M, Boemio A, Onorato L, Rinaldi L, Minichini C, Adinolfi LE, Sagnelli E, Mastrullo L, Coppola N. Marrone A, et al. J Viral Hepat. 2018 Feb;25(2):198-204. doi: 10.1111/jvh.12802. Epub 2017 Nov 29. J Viral Hepat. 2018. PMID: 29029365
84 results